Prana Surgical

The era of “precision” lung surgery is an exciting development that has the potential to make a significant impact on the field of lung cancer treatment in the years to come.

‍To address the need for right-sizing surgical management options, Prana Surgical is developing the Prana System. The Prana System allows clinicians to safely extract pulmonary nodules or other concerning tissue.

Jay Salazar, Director of Product Strategy, and Dr. Richard Fischel, Chief Medical Officer and Co-Founder, attended ISMICS 2023 in Boston.

Prana Thoracic is rebranding as Prana Surgical, marking a shift toward broader surgical innovation beyond lung cancer treatments.

Prana Surgical, a Houston-based medical device company, announced today that the U.S. Food and Drug Administration (FDA) has granted clearance forthe Prana System, an electrosurgical device indicated to remove tissue and control bleeding.

Prana Surgical appoints Natasha (Tasha) Bond as COO as it scales commercialization after FDA clearance of the Prana System.

First-in-human procedures mark a critical milestone supporting the system’s clinical development

The company develops surgical technologies to improve outcomes for physicians and patients.

A minimally invasive, lung-sparing device that will provide physicians and patients with the certainty they need to move forward with treatment.

The Privacy Policy for pranathoracic.com

A new **FDA-cleared diagnostic tool** helps detect **lung cancer in women**, addressing a mortality rate that surpasses combined deaths from breast, ovarian, and cervical cancers. The tool targets early identification of lung nodules, potentially improving survival outcomes. The innovation reflects growing efforts to combat lung cancer, a leading cause of cancer-related deaths in women.

Aug 2026ForbesNews article

Prana Surgical secures FDA clearance for its **Prana System**, an electrosurgical tool designed for operating rooms. The device represents the company’s first FDA-approved product, marking a key milestone in its commercialization efforts. The Houston-based startup now prepares for broader market adoption in U.S. surgical settings.

Apr 2026InnovationMapNews article

Prana Surgical secures FDA clearance for its **Prana System**, an image-guided platform designed for minimally invasive, tissue-sparing surgical excisions. The system aims to enhance precision in procedures while reducing patient trauma. The technology targets improved surgical outcomes through advanced imaging integration.

Apr 2026PRWebNews article

Prana Thoracic raises an extra $3 million in a Series A extension to advance its lung cancer diagnostic technology. The Houston-based medtech startup develops tools intended to improve early intervention for lung cancer patients. The funding supports further development of its proprietary diagnostic platform.

Aug 2024InnovationMapNews article